Evidence map›Paper›PMID 39555102›Full record

ReviewFrontiers in pharmacology2024

Advances of curcumin in nervous system diseases: the effect of regulating oxidative stress and clinical studies.

Yuxun Wei, Hong Li, Yue Li, Yue Zeng, Tian Quan, Yanen Leng, En Chang, Yingtao Bai, Yuan Bian, Yi Hou

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuxun Wei *Pharmacy Department, Clinical Trial Institution, The People's Hospital of Zhongjiang, Deyang, China.
Hong Li *West China School of Medicine, Sichuan University, Chengdu, China.
Yue LiMolecular Urooncology, Department of Urology, Klinikum Rechts der Isar, Technical University of Munich, München, Germany.
Yue ZengPharmacy Department, Clinical Trial Institution, The People's Hospital of Zhongjiang, Deyang, China.
Tian QuanPharmacy Department, Clinical Trial Institution, The People's Hospital of Zhongjiang, Deyang, China.
Yanen LengPharmacy Department, Clinical Trial Institution, The People's Hospital of Zhongjiang, Deyang, China.
En ChangPharmacy Department, Clinical Trial Institution, The People's Hospital of Zhongjiang, Deyang, China.
Yingtao BaiPharmacy Department, Clinical Trial Institution, The People's Hospital of Zhongjiang, Deyang, China.
Yuan BianDepartment of Oncology, 363 Hospital, Chengdu, China.
Yi HouPharmacy Department, Clinical Trial Institution, The People's Hospital of Zhongjiang, Deyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, researchers have highly observed that neurological disorders (NSDs) with the aging of the population are a global health burden whose prevalence is increasing every year. Previous evidence suggested that the occurrence of neurological disorders is correlated with predisposing factors such as inflammation, aging, and injury. Particularly, the neuronal cells are susceptible to oxidative stress, leading to lesions caused by high oxygen-consuming properties. Oxidative stress (OS) is a state of peroxidation, which occurs as a result of the disruption of the balance between oxidizing and antioxidizing substances. The oxidative intermediates such as free radicals, hydrogen peroxide (H

Indexed as

antioxidant propertiescurcuminmolecular mechanismneurological disordersoxidative stress

Identifiers

PMID39555102
PMCPMC11563972

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.